These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14644619)

  • 1. Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.
    Danielsson BR; Sköld AC; Johansson A; Dillner B; Blomgren B
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):168-76. PubMed ID: 14644619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs?
    Azarbayjani F; Danielsson BR
    Epilepsia; 2002 May; 43(5):457-68. PubMed ID: 12027905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.
    Danielsson BR; Danielsson C; Nilsson MF
    Reprod Toxicol; 2007 Jul; 24(1):42-56. PubMed ID: 17570632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia.
    Sköld AC; Danielsson C; Linder B; Danielsson BR
    Reprod Toxicol; 2002; 16(4):333-42. PubMed ID: 12220593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.
    Ritchie HE; Ababneh DH; Oakes DJ; Power CA; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):144-53. PubMed ID: 23504928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity.
    Webster WS; Brown-Woodman PD; Snow MD; Danielsson BR
    Teratology; 1996 Mar; 53(3):168-75. PubMed ID: 8761884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs.
    Nilsson MF; Danielsson C; Sköld AC; Johansson A; Blomgren B; Wilson J; Khan KM; Bengtsson E; Kultima K; Webster WS; Danielsson BR
    Reprod Toxicol; 2010 Apr; 29(2):156-63. PubMed ID: 20144703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin teratogenicity: hypoxia marker and effects on embryonic heart rhythm suggest an hERG-related mechanism.
    Danielsson BR; Johansson A; Danielsson C; Azarbayjani F; Blomgren B; Sköld AC
    Birth Defects Res A Clin Mol Teratol; 2005 Mar; 73(3):146-53. PubMed ID: 15744730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism.
    Sköld AC; Wellfelt K; Danielsson BR
    Teratology; 2001 Dec; 64(6):292-300. PubMed ID: 11754171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.
    Danielsson BR; Skold AC; Azarbayjani F
    Curr Pharm Des; 2001 Jun; 7(9):787-802. PubMed ID: 11375779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New proposals for testing drugs with IKr-blocking activity to determine their teratogenic potential.
    Karlsson M; Danielsson BR; Nilsson MF; Danielsson C; Webster WS
    Curr Pharm Des; 2007; 13(29):2979-88. PubMed ID: 17979741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.
    Danielsson C; Brask J; Sköld AC; Genead R; Andersson A; Andersson U; Stockling K; Pehrson R; Grinnemo KH; Salari S; Hellmold H; Danielsson B; Sylvén C; Elinder F
    Cardiovasc Res; 2013 Jan; 97(1):23-32. PubMed ID: 22997158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.
    Azarbayjani F; Danielsson BR
    Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity.
    Danielsson C; Azarbayjani F; Sköld AC; Sjögren N; Danielsson BR
    Birth Defects Res A Clin Mol Teratol; 2007 Aug; 79(8):595-603. PubMed ID: 17584909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities.
    Sköld AC; Danielsson BR
    Arzneimittelforschung; 2000 Jun; 50(6):520-5. PubMed ID: 10918943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of macrolide antibiotics on rat embryonic heart function in vitro.
    Nilsson MF; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):189-98. PubMed ID: 24753334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species.
    Wellfelt K; Sköld AC; Wallin A; Danielsson BR
    Reprod Toxicol; 1999; 13(2):93-101. PubMed ID: 10213516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.
    Danielsson B; Webster WS; Ritchie HE
    Reprod Toxicol; 2018 Oct; 81():237-245. PubMed ID: 30149139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of drugs with ion channel-blocking activity on the early embryonic rat heart.
    Abela D; Ritchie H; Ababneh D; Gavin C; Nilsson MF; Khan MK; Carlsson K; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):429-40. PubMed ID: 20973055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.
    Danielsson B; Sköld AC; Azarbayjani F; Ohman I; Webster W
    Toxicol Appl Pharmacol; 2000 Mar; 163(2):164-75. PubMed ID: 10698674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.